Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 8/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 5/20 | 0.34 |
| ▸ | NAAA | Q02083 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3950547 | 0.99 | EPHX2 (0.38) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL3957275 | 0.97 | EPHX2 (0.39) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL3950061 | 0.96 | TSHR (0.39) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL3954115 | 0.96 | TSHR (0.35) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL38998 | 0.95 | KMT2A (0.38) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL524344 | 0.94 | NAAA (0.39) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL21582136 | 0.94 | NAAA (0.39) | EPHX2KMT2AMEN1GAATSHR | |
| SCHEMBL39302 | 0.92 | KMT2A (0.38) | KMT2AMEN1GAATSHRNAAA | |
| SCHEMBL39577 | 0.92 | KMT2A (0.35) | KMT2AMEN1GAATSHRSMN1; SMN2 | |
| SCHEMBL7692226 | 0.90 | KMT2A (0.35) | EPHX2KMT2AMEN1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1379587-B1 | LONG CHAIN HINDERED AMINES AND COMPOSITIONS STABILIZED THEREWITH | CIBA SC HOLDING AG (CH) | 2005-02-02 | — | — | EP | disclosed |
| US-6699298-B2 | DISCOLORATION INHIBITION CANDLE WAX | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-03-02 | — | — | US | disclosed |
| EP-1379587-A1 | LONG CHAIN HINDERED AMINES AND COMPOSITIONS STABILIZED THEREWITH | Ciba SC Holding AG (CH) | 2004-01-14 | — | — | EP | disclosed |
| US-20030109704-A1 | Long chain hindered amines and compositions stabilized therewith | WOOD MERVIN G (US) | 2003-06-12 | — | — | US | disclosed |
| WO-2002083781-A1 | LONG CHAIN HINDERED AMINES AND COMPOSITIONS STABILIZED THEREWITH | CIBA SPECIALTY CHEMICALS HOLDING INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| US-6465645-B1 | CONTAINING TRIAZINE GROUPS AND N-ALKYLOXYPIPERIDINE GROUPS; CANDLE WAX WHICH IS EFFECTIVELY STABILIZED AGAINST DISCOLORATION AND FADING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109704-A1 | Long chain hindered amines and compositions stabilized therewith | TYR, DDC, AOC2 | EPHX2 772/4885KMT2A 3322/4885MEN1 2859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.